Deutsche Bank’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.2M | Sell |
368,878
-11,270
| -3% | -$128K | ﹤0.01% | 1310 |
|
|
2025
Q1 | $4.52M | Sell |
380,148
-151,049
| -28% | -$1.79M | ﹤0.01% | 1284 |
|
|
2024
Q4 | $10M | Sell |
531,197
-323,485
| -38% | -$6.09M | ﹤0.01% | 1022 |
|
|
2024
Q3 | $19.2M | Sell |
854,682
-193,712
| -18% | -$4.35M | 0.01% | 841 |
|
|
2024
Q2 | $21.9M | Sell |
1,048,394
-450,974
| -30% | -$9.41M | 0.01% | 792 |
|
|
2024
Q1 | $22M | Buy |
1,499,368
+995,163
| +197% | +$14.6M | 0.01% | 784 |
|
|
2023
Q4 | $5.2M | Buy |
504,205
+484,610
| +2,473% | +$5M | ﹤0.01% | 1234 |
|
|
2023
Q3 | $154K | Buy |
19,595
+3,841
| +24% | +$30.2K | ﹤0.01% | 2914 |
|
|
2023
Q2 | $157K | Sell |
15,754
-12,659
| -45% | -$126K | ﹤0.01% | 3022 |
|
|
2023
Q1 | $252K | Buy |
28,413
+8,667
| +44% | +$77K | ﹤0.01% | 2891 |
|
|
2022
Q4 | $217K | Buy |
19,746
+310
| +2% | +$3.4K | ﹤0.01% | 2929 |
|
|
2022
Q3 | $253K | Sell |
19,436
-1,527
| -7% | -$19.9K | ﹤0.01% | 2789 |
|
|
2022
Q2 | $266K | Buy |
20,963
+3,011
| +17% | +$38.2K | ﹤0.01% | 2982 |
|
|
2022
Q1 | $252K | Sell |
17,952
-2,018
| -10% | -$28.3K | ﹤0.01% | 3108 |
|
|
2021
Q4 | $578K | Buy |
19,970
+677
| +4% | +$19.6K | ﹤0.01% | 2726 |
|
|
2021
Q3 | $578K | Sell |
19,293
-582
| -3% | -$17.4K | ﹤0.01% | 2916 |
|
|
2021
Q2 | $527K | Buy |
19,875
+4,130
| +26% | +$110K | ﹤0.01% | 3172 |
|
|
2021
Q1 | $490K | Buy |
15,745
+2,709
| +21% | +$84.3K | ﹤0.01% | 3100 |
|
|
2020
Q4 | $429K | Buy |
13,036
+7,105
| +120% | +$234K | ﹤0.01% | 2986 |
|
|
2020
Q3 | $207K | Buy |
+5,931
| New | +$207K | ﹤0.01% | 3159 |
|